Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin ...
Q2 2026
Aug 4, 2026
Q1 2026
May 6, 2026
FY 2025
Feb 18, 2026
Q4 2025
Q3 2025
Nov 5, 2025